Lv11
30 积分 2025-08-21 加入
Clinical Pharmacokinetics and Immunogenicity Evaluation of a Trop-2-Targeted Antibody-Drug Conjugate FDA018 in Patients with Epithelial Malignant Solid Tumors
1小时前
求助中
Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes
14天前
已完结
Antibody-drug conjugates: A review of cutaneous adverse effects
17天前
已完结
Computational Modeling for Circulating Cell-Free DNA in Clinical Oncology
1个月前
已关闭
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
2个月前
已完结
Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies
2个月前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
3个月前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
3个月前
已完结
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
3个月前
已完结
皖公网安备34019202002308
